Cargando…
Neuroprotective effects of HTR1A antagonist WAY-100635 on scopolamine-induced delirium in rats and underlying molecular mechanisms
BACKGROUND: Limited surveys have assessed the performance of 5-hydroxytreptamine receptor 1A and its antagonist WAY-100635 in pharmacological manipulations targeting delirium therapies. The purpose of this paper was to assess the central pharmacological activity of WAY-100635 in a rat model of scopo...
Autores principales: | Qiu, Yimin, Chen, Dongmei, Huang, Xiaojing, Huang, Lina, Tang, Liang, Jiang, Jihong, Chen, Lianhua, Li, Shitong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070354/ https://www.ncbi.nlm.nih.gov/pubmed/27760517 http://dx.doi.org/10.1186/s12868-016-0300-9 |
Ejemplares similares
-
WAY-100635 Alleviates Corneal Lesions Through 5-HT(1A) Receptor-ROS-Autophagy Axis in Dry Eye
por: Zhou, Xujiao, et al.
Publicado: (2021) -
Reliable set-up for in-loop (11)C-carboxylations using Grignard reactions for the preparation of [carbonyl-(11)C]WAY-100635 and [(11)C]-(+)-PHNO()
por: Rami-Mark, Christina, et al.
Publicado: (2013) -
Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study With (11)C-WAY-100635 and (18)F-MPPF
por: Kitamura, Soichiro, et al.
Publicado: (2023) -
POCD in patients receiving total knee replacement under deep vs light anesthesia: A randomized controlled trial
por: Hou, Ruixue, et al.
Publicado: (2018) -
Scopolamine promotes neuroinflammation and delirium-like neuropsychiatric disorder in mice
por: Cheon, So Yeong, et al.
Publicado: (2021)